Skip to content

Clinical trials

Completed Phase 2 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 2 Status: Completed Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20032
20044
20052
20064
20072
20082
20091
20102
20122
20132
20141
20153
20175
20181
20195
20202
20211
20223
20235
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
National Institute of Mental Health (NIMH)5
Vanderbilt University Medical Center3
Clexio Biosciences Ltd.2
H. Lundbeck A/S2
Marinus Pharmaceuticals2
Merck Sharp & Dohme LLC2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Sanofi2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder58
Major Depressive Disorder25
Mood Disorders12
Bipolar Disorder6
Mental Disorders5
Anxiety Disorders4
Anhedonia2
Cognitive Dysfunction2
Depression, Postpartum2
Depressive Disorder, Treatment-Resistant2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.